GENERAL BIOLOGICAL CORP financial statements, including revenue, expenses, profit, and loss
The total revenue of 4117 for the last semiannual is 131.13 M TWD, and it's 1.92% lower compared to the previous semiannual. The net income of H2 23 is -103.29 M TWD.